Dystrophin and the a-dystrobrevins bind directly to the adapter protein syntrophin to form membrane-associated scaffolds. At the blood-brain barrier, a-syntrophin colocalizes with dystrophin and the a-dystrobrevins in perivascular glial endfeet and is required for localization of the water channel aquaporin-4. Earlier we have shown that localization of the scaffolding proteins c2-syntrophin, a-dystrobrevin-2, and dystrophin to glial endfeet is also dependent on the presence of a-syntrophin. In this study, we show that the expression levels of a-syntrophin, c2-syntrophin, and dystrophin at the blood-brain barrier are reduced in a-dystrobrevin-null mice. This is the first demonstration in which assembly of an astroglial protein scaffold containing syntrophin and dystrophin in perivascular astrocytes is dependent on the presence of a-dystrobrevin.
Introduction
Since the discovery of dystrophin as the product of the Duchenne muscular dystrophy gene, numerous proteins have been identified that associate with dystrophin to form membrane-based scaffolds (reviewed in Refs [1, 2] ). These dystrophin-associated scaffolds provide structural integrity to the cell by connecting the extracellular matrix with the cytoskeleton and create intracellular docking points for regulatory proteins. The dystrobrevins are a family of proteins that interact directly with dystrophin and syntrophin adapter proteins, providing a link to a network of signaling proteins that regulate key cellular processes such as water transport and nitric oxide-mediated events [3] [4] [5] . Two separate dystrobrevin genes named a-dystrobrevin and b-dystrobrevin have been identified, both of which yield multiple transcripts [6] [7] [8] [9] [10] . Alphadystrobrevin and b-dystrobrevin are both expressed in brain but have distinct locations [8] .
The a-dystrobrevin isoforms (currently six have been identified) have been characterized most thoroughly in muscle where several isoforms are required for proper formation of the neuromuscular synapse [11] . However, the dystrobrevins are also present in the neurons and glia of the brain [10] [11] [12] [13] [14] [15] [16] . Immunofluorescence studies show a-dystrobrevin at glial endfeet and endothelial cells at the blood-brain barrier [13, 15] , whereas a-dystrobrevin-1 and a-dystrobrevin-2 localize specifically to glial endfeet [12, 16] . Earlier we have shown that the localization of a-dystrobrevin-2 to glial endfeet at the blood-brain barrier is specifically dependent on the presence of a-syntrophin [16] . Using the a-dystrobrevin-null mouse, we now show that the expression levels of a-syntrophin, g2-syntrophin, and dystrophin in the vasculature are dependent on a-dystrobrevin. These data indicate that a-syntrophin and a-dystrobrevin are mutually dependent on each other and that a-dystrobrevin plays a critical role in assembly of the dystrophin-associated protein complex (DAPC) at the blood-brain barrier.
Methods
The syntrophin antibodies used in this study were mAb1351 (Affinity Bioreagents, now Thermo Scientific, Rockford, Illinois, USA; MA1-745), which recognizes asyntrophin, b1-syntrophin, and b2-syntrophin, and syntrophin isoform-specific affinity-purified rabbit polyclonal antibodies to a-syntrophin (Syn17; [17] ) and g2-syntrophin (Ab 212; [16, 18, 19] ). The dystrophin (MANDRAmouse monoclonal) was purchased from Sigma (St Louis, Missouri, USA) and the a-dystrobrevin antibodies (Ab 638, Ab a-dystrobrevin-2-rabbit polyclonals) have been characterized earlier [20, 21] .
For immunofluorescence, animals were killed in accordance with the National Institutes of Health guide for the care of laboratory animals. After light sedation with carbon dioxide gas, 6-week-old and 3-month-old male C57Bl6, a-dystrobrevin-null mice [22] , and corresponding wild-type littermates were quickly killed and brains were dissected. Cerebella were removed, bisected, and placed in phosphate buffer saline containing 4% paraformaldehyde/10% sucrose for 12 min in ice. Cerebellar tissue was then transferred to phosphate buffer saline containing 25% sucrose and placed at 41C overnight. Tissue was embedded in optimal cutting temperature compound and frozen in isopentane cooled with liquid nitrogen. Twenty-micron thick cryosections were adhered to superfrost plus slides (VWR International, LLC, West Chester, Pennsylvania, USA) and stored at -801C. Immunofluorescence and confocal images were collected in identical conditions, as described earlier [15] .
Results
The assembly of the DAPC at the blood-brain barrier is dependent on the presence of a-syntrophin [16] . Specifically, a-syntrophin is required for the localization of g2-syntrophin, a-dystrobrevin-2, and dystrophin to the perivascular astrocyte endfoot membrane. As localization of a-dystrobrevin-2, but not a-dystrobrevin-1, requires a-syntrophin, we investigated how the DAPC was affected by the loss of a-dystrobrevin isoforms. We performed immunolocalization for a-syntrophin on brains from a-dystrobrevin-null animals ( Fig. 1d-f ) [22] and wild-type littermates ( Fig. 1a-c ). The merged image in Fig. 1c indicates that, in wild-type mice, a-syntrophin colocalizes with a-dystrobrevin-1 in perivascular astrocyte endfeet, as reported earlier. Furthermore, we observed a striking decrease in the level of a-syntrophin immunofluorescence in the a-dystrobrevin-null mice (compare Fig. 1e with b).
Earlier we have shown that the localization of g2-syntrophin to perivascular endfeet is dependent on a-syntrophin [16] . As we found that expression of a-syntrophin at glial endfeet is dependent on the presence of a-dystrobrevin, we determined whether the localization of g2-syntrophin was disrupted by the loss of a-dystrobrevin. We compared g2-syntrophin immunolocalization (green, Fig. 2b and e) in wild type ( Fig. 2a-c) and in a-dystrobrevin-null ( Fig. 2d-f ) cerebellum. g2-syntrophin immunofluorescence was reduced in the surrounding cerebellar vasculature in the absence of a-dystrobrevin (compare Fig. 2e with b) . As in the a-syntrophin-null animals [16] , g2-syntrophin expression is unaffected in neurons (see arrows, Fig. 2 ). Taken together, these data indicate that expression of g2-syntrophin in nonneuronal cells is dependent on both a-syntrophin and a-dystrobrevin.
Dystrophin colocalizes with a-syntrophin in both the granular layer and the molecular layer of the cerebellum. The a-dystrobrevin-1 and a-dystrobrevin-2 isoforms exhibit discrete distributions in the vasculature of these layers but both colocalize with a-syntrophin. Thus, dystrophin and a form of a-dystrobrevin are colocalized in the vasculature throughout the cerebellum. Dystrophin localization at the blood-brain barrier is contingent on the presence of a-syntrophin [16] . As a-syntrophin localization is disrupted in the a-dystrobrevin-null mice, the localization of dystrophin might also be affected. We assessed 
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Alpha-syntrophin is reduced at the blood-brain barrier in the absence of a-Db. We performed double-immunolabeling for a-Db-1 (red, a, d) and syntrophin (green, b, e) in wild type (a-c) and a-Db-null (d-f) adult mouse cerebellum. Alpha-syntrophin and a-Db-1 colocalize in perivascular astrocyte endfeet (see merged image, 1c). We observed a reduction in fluorescence intensity for a-syntrophin in the brains of a-Db-null mice (e), indicating that localization of a-syntrophin to perivascular astrocyte endfeet is dependent on a-Db. The pan-syntrophin antibody (mAb 1351; b, e) or an a-syntrophin-specific rabbit polyclonal antibody (Syn17, data not shown) was used to recognize a-syntrophin and an a-Db-1 specific rabbit polyclonal [23] was used to localize a-Db-1. As expected, a-Db-1 is absent in the a-Db-null cerebellum (d).
(c and f) are merged images of (a, b) and (d, e), respectively. Scale bar, 25 mm. a-Db-1, a-dystrobrevin-1. αDb-1 γ2-Syntrophin Merge
Gamma2-syntrophin is reduced at the blood-brain barrier in the absence of a-Db. We performed double-immunolabeling for a-Db-1 (red, a, d) and g2-syntrophin (green, b, e) in wild-type (a-c) and a-Db-null (d-f) adult mouse cerebellum. As shown earlier [16] , g2-syntrophin localizes to Purkinje neurons and to astrocyte endfeet in the adult cerebellum (b). In the absence of a-Db (e), g2-syntrophin is reduced in astrocyte endfeet but unaffected in Purkinje neurons (see arrows). As expected, a-Db-1 labeling is lost in the a-Db-null animals (d).
(c and f) are merged images of (a, b) and (d, e), respectively. Scale bar, 25 mm. a-Db-1, a-dystrobrevin-1. 
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Dystrophin is reduced at the blood-brain barrier in the absence of a-Db. We performed double-immunolabeling for a-Db-2 (red, a, d) and dystrophin (green, b, e) in wild-type (a-c) and a-Db-null (d-f) adult mouse cerebellum. a-Db-2 is restricted to the blood-brain barrier in the granular layer of cerebellum (see arrows, a), whereas dystrophin localizes to the blood-brain barrier throughout the cerebellar cortex (b). In a-Db-null cerebellum (d-f), labeling for a-Db-2 is absent (d), and immunolocalization of dystrophin is reduced (e). Arrows in (c) denote colocalization of a-Db-2 and dystrophin in the granular layer of cerebellum. (c) and (f) are merged images of (a, b) and (d, e), respectively. gran, granular layer; mol, molecular layer. Scale bar, 25 mm. a-Db-2, a-dystrobrevin-2.
Dystrophin-associated scaffolding Bragg et al. 697 immunofluorescence for dystrophin (green, Fig. 3b and e ) and a-dystrobrevin-2 (red, Fig. 3a and d) in cerebellum from wild type (Fig. 3a-c) and a-dystrobrevin-null mice ( Fig. 3d-f ). As shown earlier, a-dystrobrevin-2 is present in the granular layer of cerebellar cortex (Fig. 3a, see  arrows) . As expected, the a-dystrobrevin-null cerebellum is negative for a-dystrobrevin-2 (Fig. 3d ). Dystrophin is associated with the blood-brain barrier throughout the cerebellar cortex (Fig. 3b) , and its expression levels are substantially reduced in the a-dystrobrevin-null mouse (compare Fig. 3e with b ).
Discussion
Taken together with our earlier published results [16] , the main finding of this study is that a-syntrophin and a-dystrobrevin are mutually dependent on one another for their expression and/or localization in the cerebrovasculature. Our earlier conclusion [16] that a-syntrophin is the central regulator of the DAPC at endfeet must now be modified to include the a-dystrobrevin/a-syntrophin subcomplex. Whether other syntrophin isoforms are required, remains to be determined. Interestingly, codependence of a-syntrophin and a-dystrobrevin occurs also in skeletal muscle fibers. In mice that are lacking a-syntrophin, sarcolemmal-staining intensity for a-dystrobrevin-1 and a-dystrobrevin-2 is also decreased [24] . Likewise, in adystrobrevin-null mice, levels of a-syntrophin, b1-syntrophin, and b2-syntrophin were decreased [11, 22] .
How might these protein members of the dystrophin complex be mutually dependent on each other for proper localization? One possibility is that they are assembled into a vesicular complex [25, 26] before transporting to glial endfeet. In this capacity, loss of either protein may have effects downstream in the trafficking pathway. Alternatively, a-syntrophin and a-dystrobrevin may act in concert to retain the components of the DAPC at the cellular plasma membrane. Future experiments using endothelialastrocyte cocultures from normal and a-syntrophin-null mice may be informative in revealing the dynamics of DAPC complex trafficking, assembly, and stability at the blood-brain interface.
Loss of either a-syntrophin or a-dystrobrevin results in reduction of dystrophin from the vasculature. In skeletal muscle, dystrophin is considered as the central component of the DAPC whose presence is critical for sarcolemmal localization of a-dystrobrevins and certain syntrophin isoforms [11, 22, 24] . The absence of a-dystrobrevins and syntrophins do not affect sarcolemmal dystrophin levels. Thus, despite some similarities discussed above, assembly and/or maintenance of this dystrophin-associated subcomplex may be regulated differentially in brain and skeletal muscle.
Conclusion
We show, for the first time, that the loss of a-dystrobrevin results in the decreased expression of a-syntrophin, g2-syntrophin, and dystrophin in astrocytes. Taken together with our earlier study [16] , these data indicate that both a-syntrophin and a-dystrobrevin are essential for the proper assembly and maintenance of the dystrophin-based scaffold in the cerebrovasculature. Therefore, altered expression of either of these proteins could compromise both the structural and signaling functions of this scaffold.
